Cross-sectional comparison of cannabis use in adults with neuropathic versus non-neuropathic pain
Abstract Introduction: Cannabis has been decriminalized by many states and shows promise in treating both neuropathic and non-neuropathic pain through…
Abstract Introduction: Cannabis has been decriminalized by many states and shows promise in treating both neuropathic and non-neuropathic pain through…
Abstract Preclinical data suggest that cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) modulate inflammatory pathways (e.g., NLRP3, NF-κB, and PPAR-γ), but clinical…
Abstract Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest and most treatment-resistant cancers, with limited progress in improving…
Abstract Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1186/s12917-025-05122-y. Article type: Research Article Keywords: Cannabidiol…
Abstract Introduction: Cannabidiol (CBD) is widely available over the counter for presumed medical and recreational purposes. Despite its non-psychoactive nature,…
Abstract Background: Lung cancer is one of the most prevalent and lethal cancers worldwide, with limited therapeutic options in advanced…
Abstract Oral cannabidiol (CBD) product use is increasing despite suboptimal pharmacokinetics (PK) of currently available formulations. This study aimed to…
Abstract As the global population ages, the need for effective interventions to support cognitive health in older adults is growing.…
Abstract Cannabidiol (CBD), a non-psychoactive phytocannabinoid derived from Cannabis sativa L., has emerged as a promising multifunctional agent in dermatology…
Abstract This review aims to assess the therapeutic potential of cannabinoids as complementary treatments for atopic dermatitis. Atopic dermatitis (AD)…